Steven Cohen T2 Biosystems, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 15, 2019	SELL	$0.58 - $3.01 $348,000 - $1.81 Million	-600,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.56 - $4.48 $722,810 - $1.26 Million	282,348 Added 88.89%	600,000 $1.58 Million
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $59,147 - $136,157	-19,848 Reduced 5.88%	317,652 $956,000
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $1.13 Million - $1.81 Million	189,000 Added 127.27%	337,500 $2.61 Million
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $6,315 - $10,500	-1,500 Reduced 1.0%	148,500 $964,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $6.78 $585,000 - $1.02 Million	150,000	150,000 $630,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.6M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.